Researches – Page 21 – media

Hep C Antibody Test

The hepatitis C antibody test detects antibodies for the hepatitis C virus in the blood. Antibodies in the body indicate that a person has been infected with the virus at some point. However, it does not always mean that they still have the virus.
- Source: Medical News Today
- 930
- July 10, 2018
health tips hepatitis C Researches
Viscofan to Trial Stem Cell Implant for Severe Cardiac Insufficiency

Viscofan BioEngineering, a German medical products manufacturer is to conduct a Phase I clinical trial of its stem cell implant, VB-C01, designed to treat severe cardiac insufficiencies, on receiving a green light from the Spanish Agency for Medicines (AEMPS).
- Source: Verdict Medical Devices
- 755
- July 10, 2018
cardiovascular Researches stem cells
Red Wine and Green Tea could Treat Congenital Inborn Metabolic Diseases

A research team from Tel Aviv University suggested that red wine and green tea could treat certain congenital metabolic diseases, by blocking toxic metabolite formations. Since people with inborn metabolic disorders are born with a defective gene, it leads to a critical enzyme deficiency. Since there is no cure, many patients with congenital metabolic disorders are required to follow a lifelong strict diet.
- Source: Science Daily
- 548
- July 10, 2018
metabolic disease Researches
Smart Bandage to Enhance Wound Healing

The smart bandages used in this research work were designed with heating elements and thermo-responsive drug carriers in order to deliver timely treatments. It combines both temperature and pH sensors to track the signs of infection.
- Source: The Verge
- 1,410
- July 10, 2018
medical device products Researches
Baclofen, ‘Wonder Drug’ for Alcohol Use Disorder Proves to be Unsuccessful

Baclofen, which was once used to treat spasticity, has started seeing an increase as a prescription for alcohol use disorders. The advantage of Baclofen is that it could be discharged easily through the kidneys to a great extent. Scientists addressed it as a wonder drug due to its effective treatment for alcoholism.
- Source: TechExplorist
- 555
- July 9, 2018
alcohol Researches
Recent Developments in HBV Diagnosis & Treatment

Hepatitis B virus (HBV) causes liver disease that leads to one million deaths throughout the world every year. Extensive research is going on to find the most effective, quick and accurate diagnostic measures followed by therapeutic solutions.
- Source: News Medical
- 678
- July 9, 2018
hepatitis B Researches
Gene Editing Control Using Amino Acids

Gene editing and gene therapy can delete disease-causing genes in order to treat specific diseases. But the skill to control unwanted genes is a point of concern, as it might cause severe side effects. A research team from Cardiff University and the University of Bath have devised a switch to control protein expression in mouse embryos, which could be used in human gene therapies in future.
- Source: FierceBiotech
- 652
- July 9, 2018
CRISPR-Cas9 Researches
Novel Blood Test to Determine Right Time for Drug Administration

The research team claimed that the effectiveness of drugs depends on the time of administration on a personalized level. Their goal was to identify the biomarkers in blood to characterize the ‘internal time’ of an individual.
- Source: The Verge
- 696
- July 6, 2018
blood test pharmaceutical drugs Researches
Zika Virus Detection Using Smartphone Based NBC Detection Tool

Using nanotechnology, the research team developed tiny platinum nanomotors to target Zika and microbeads to bind the virus. When they are added to a sample containing Zika, a 3D complex is formed which moves in the presence of hydrogen peroxide. This unique motion signal can be perceived using a smartphone by attaching it to a cost-effective optical device. The 3D Zika complex moves rapidly compared to the slower movement of other non-target viruses.
- Source: The Verge
- 1,549
- July 6, 2018
mHealth Researches Zika
Increased Bilirubin can Reduce Cardiovascular Risk

This research study was conducted on 100,000 participants including both HIV and non-HIV patients, aged around 48 years on an average. The results were published in the Journal of the American Heart Association where the participants with higher levels of bilirubin had 76% risk for cardiovascular diseases as same as the group with the lower bilirubin levels.
- Source: India Times
- 658
- July 5, 2018
heart disease Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.